IMA (or the albumin cobalt binding test) is used as a novel and sensitive marker of ischemia and oxidative stress mainly for myocardial infarction and various diseases related to ischemia, including peripheral vascular disease, skeletal muscle ischemia, and diabetes mellitus [33,34,35,36]. This evidence concerns the gene ALB and myocardial infarction.